Prosecution Insights
Last updated: October 25, 2026

Abionic SA

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Abionic SA currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. COUNTS, GARY W is the busiest examiner, responsible for 1 pending office action.

The 2 pending office actions are assigned to 2 distinct examiners. This prosecution involves 2 distinct art units within the biotechnology sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COUNTS, GARY W 1 58.9% +29.7%
BLUMEL, BENJAMIN P 1 70.7% +30.6%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18708393 METHOD FOR THE MANAGEMENT OF ANTIBIOTIC ADMINISTRATION COUNTS, GARY W —
18251321 METHOD FOR ASSESSING THE SEVERITY OF SARS BLUMEL, BENJAMIN P —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18708393 METHOD FOR THE MANAGEMENT OF ANTIBIOTIC ADMINISTRATION COUNTS, GARY W —
18251321 METHOD FOR ASSESSING THE SEVERITY OF SARS BLUMEL, BENJAMIN P —

Top Art Units

Art UnitApps
1678 1
1671 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18708393 METHOD FOR THE MANAGEMENT OF ANTIBIOTIC ADMINISTRATION COUNTS, GARY W 1678 §101§102§103§112 Non-Final OA — Pending May 08, 2024
18251321 METHOD FOR ASSESSING THE SEVERITY OF SARS BLUMEL, BENJAMIN P 1671 §101§103§112 Final Rejection — Pending May 01, 2023

Managing Abionic SA's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Abionic SA have?

Abionic SA has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Abionic SA applications?

Gary W Counts has the most, with 1 of Abionic SA's pending office actions.

What technology area are Abionic SA's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month